MAP1LC3A
MOLECULAR TARGETmicrotubule associated protein 1 light chain 3 alpha
MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MAP1LC3A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Novobiocin | 1.39 | 3 |
| 2 | Fluspirilene | 0.69 | 1 |
| 3 | Mestranol | 0.69 | 1 |
| 4 | Tolazamide | 0.69 | 1 |
| 5 | Trifluridine | 0.69 | 1 |
About MAP1LC3A as a Drug Target
MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented MAP1LC3A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MAP1LC3A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.